Wedbush Securities’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $203K | Buy |
+1,108
| New | +$204K | 0.01% | 1129 |
|
|
2025
Q4 | – | Sell |
-2,017
| Closed | -$283K | – | 1209 |
|
|
2025
Q3 | $283K | Buy |
2,017
+46
| +2% | +$6.22K | 0.01% | 888 |
|
|
2025
Q2 | $248K | Buy |
1,971
+436
| +28% | +$54.3K | 0.01% | 937 |
|
|
2025
Q1 | $210K | Buy |
+1,535
| New | +$219K | 0.01% | 988 |
|
|
2024
Q4 | – | Sell |
-1,103
| Closed | -$214K | – | 1145 |
|
|
2024
Q3 | $214K | Sell |
1,103
-338
| -23% | -$70.7K | 0.01% | 963 |
|
|
2024
Q2 | $334K | Sell |
1,441
-289
| -17% | -$62.8K | 0.01% | 808 |
|
|
2024
Q1 | $373K | Buy |
1,730
+185
| +12% | +$43.3K | 0.01% | 765 |
|
|
2023
Q4 | $400K | Sell |
1,545
-47
| -3% | -$11.5K | 0.02% | 643 |
|
|
2023
Q3 | $409K | Buy |
1,592
+16
| +1% | +$4.28K | 0.02% | 593 |
|
|
2023
Q2 | $449K | Sell |
1,576
-400
| -20% | -$119K | 0.02% | 582 |
|
|
2023
Q1 | $549K | Buy |
1,976
+67
| +4% | +$18.5K | 0.03% | 488 |
|
|
2022
Q4 | $529K | Sell |
1,909
-53
| -3% | -$15K | 0.03% | 494 |
|
|
2022
Q3 | $524K | Sell |
1,962
-74
| -4% | -$15.7K | 0.03% | 501 |
|
|
2022
Q2 | $415K | Buy |
2,036
+204
| +11% | +$41.7K | 0.02% | 600 |
|
|
2022
Q1 | $386K | Sell |
1,832
-695
| -28% | -$151K | 0.02% | 684 |
|
|
2021
Q4 | $606K | Buy |
2,527
+113
| +5% | +$29.1K | 0.03% | 542 |
|
|
2021
Q3 | $683K | Buy |
2,414
+76
| +3% | +$24.9K | 0.03% | 475 |
|
|
2021
Q2 | $810K | Sell |
2,338
-320
| -12% | -$96.9K | 0.04% | 423 |
|
|
2021
Q1 | $744K | Buy |
2,658
+922
| +53% | +$249K | 0.04% | 425 |
|
|
2020
Q4 | $425K | Sell |
1,736
-335
| -16% | -$86.4K | 0.04% | 521 |
|
|
2020
Q3 | $588K | Sell |
2,071
-30
| -1% | -$8.37K | 0.06% | 372 |
|
|
2020
Q2 | $562K | Sell |
2,101
-261
| -11% | -$78.5K | 0.05% | 379 |
|
|
2020
Q1 | $747K | Buy |
2,362
+22
| +0.9% | +$6.68K | 0.09% | 244 |
|
|
2019
Q4 | $694K | Sell |
2,340
-179
| -7% | -$49.7K | 0.06% | 356 |
|
|
2019
Q3 | $586K | Buy |
2,519
+276
| +12% | +$64.3K | 0.06% | 386 |
|
|
2019
Q2 | $525K | Sell |
2,243
-793
| -26% | -$183K | 0.05% | 411 |
|
|
2019
Q1 | $718K | Sell |
3,036
-894
| -23% | -$282K | 0.08% | 302 |
|
|
2018
Q4 | $1.18M | Sell |
3,930
-89
| -2% | -$28.4K | 0.15% | 164 |
|
|
2018
Q3 | $1.42M | Buy |
4,019
+218
| +6% | +$75.1K | 0.16% | 139 |
|
|
2018
Q2 | $1.1M | Buy |
3,801
+363
| +11% | +$102K | 0.14% | 171 |
|
|
2018
Q1 | $941K | Sell |
3,438
-202
| -6% | -$62.7K | 0.12% | 202 |
|
|
2017
Q4 | $1.16M | Buy |
3,640
+144
| +4% | +$46.2K | 0.14% | 162 |
|
|
2017
Q3 | $1.09M | Buy |
3,496
+1
| +0% | +$296 | 0.14% | 156 |
|
|
2017
Q2 | $948K | Sell |
3,495
-97
| -3% | -$25.6K | 0.12% | 202 |
|
|
2017
Q1 | $982K | Sell |
3,592
-172
| -5% | -$48.6K | 0.13% | 186 |
|
|
2016
Q4 | $1.07M | Sell |
3,764
-449
| -11% | -$133K | 0.16% | 147 |
|
|
2016
Q3 | $1.32M | Sell |
4,213
-27
| -0.6% | -$8K | 0.2% | 108 |
|
|
2016
Q2 | $1.02M | Sell |
4,240
-520
| -11% | -$137K | 0.17% | 129 |
|
|
2016
Q1 | $1.24M | Buy |
4,760
+1,461
| +44% | +$386K | 0.22% | 102 |
|
|
2015
Q4 | $1.01M | Sell |
3,299
-781
| -19% | -$224K | 0.18% | 117 |
|
|
2015
Q3 | $1.19M | Buy |
4,080
+713
| +21% | +$235K | 0.24% | 93 |
|
|
2015
Q2 | $1.36M | Buy |
3,367
+538
| +19% | +$216K | 0.25% | 85 |
|
|
2015
Q1 | $1.2M | Buy |
2,829
+1,273
| +82% | +$502K | 0.2% | 104 |
|
|
2014
Q4 | $528K | Buy |
1,556
+135
| +10% | +$43.7K | 0.08% | 253 |
|
|
2014
Q3 | $470K | Buy |
1,421
+400
| +39% | +$132K | 0.07% | 281 |
|
|
2014
Q2 | $322K | Buy |
1,021
+111
| +12% | +$33.4K | 0.05% | 363 |
|
|
2014
Q1 | $278K | Buy |
910
+71
| +8% | +$22.5K | 0.05% | 392 |
|
|
2013
Q4 | $235K | Hold |
839
| – | – | 0.06% | 406 |
|
|
2013
Q3 | $202K | Buy |
+839
| New | +$188K | 0.05% | 434 |
|
Other funds holding BIIB
VCM
VPM
Wedbush Securities's BIIB Position: Q1 2026 in Review
Wedbush Securities opened a new position in Biogen (BIIB) in Q1 2026: 1,108 shares worth $203K. The stake represents 0.01% of the portfolio and ranks #1129 among its holdings. This is a return to the name: Wedbush Securities previously reported a position in BIIB as recently as Q3 2025.
Wedbush Securities first reported a position in BIIB in Q3 2013 and has held it in 49 quarters since. The position peaked at $1.42M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Wedbush Securities held 1,108 shares of Biogen worth $203K as of Q1 2026.
- Biogen was a new Wedbush Securities position in Q1 2026.
- Biogen made up 0.01% of Wedbush Securities's portfolio in Q1 2026, its #1129 holding.
- Wedbush Securities first reported a position in Biogen in Q3 2013 and has held it in 49 quarters since.
- Wedbush Securities's Biogen position peaked at $1.42M in Q3 2018.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.